Arnaud Dieudonne

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric study.

Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric study.

Journal: EJNMMI research

Published: January 15, 2026

Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients.

Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients.

Journal: EClinicalMedicine

Published: January 07, 2026

Comparison of pre-therapeutic [99mTc]Tc-MAA SPECT/CT and post-therapeutic 90Y-PET/CT dosimetry for outcome prediction in hepatocellular carcinoma treated with resin microspheres.

Comparison of pre-therapeutic [99mTc]Tc-MAA SPECT/CT and post-therapeutic 90Y-PET/CT dosimetry for outcome prediction in hepatocellular carcinoma treated with resin microspheres.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 15, 2025

Clinical value of per-treatment whole-body single-time-point automated dosimetry for [177Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer.

Clinical value of per-treatment whole-body single-time-point automated dosimetry for [177Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 24, 2025

Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-concept.

Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-concept.

Journal: EJNMMI physics

Published: October 02, 2024

Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.

Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 19, 2023

Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.

Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.

Journal: EJNMMI research

Published: September 13, 2023

Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment.

Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment.

Journal: EJNMMI physics

Published: May 16, 2023

Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres.

Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres.

Journal: Frontiers in nuclear medicine

Published: July 20, 2022

Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors.

Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors.

Journal: European radiology

Published: September 18, 2020

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 11, 2020

Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study.

Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study.

Journal: Radiology

Published: July 01, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026